Stocks & Investing
Fri, July 12, 2024
[ Fri, Jul 12th 2024
] - WOPRAI
Fri, May 3, 2024
[ Fri, May 03rd 2024
] - WOPRAI
Mon, March 11, 2024
[ Mon, Mar 11th 2024
] - WOPRAI
Wed, February 28, 2024
[ Wed, Feb 28th 2024
] - WOPRAI
Mon, February 12, 2024
[ Mon, Feb 12th 2024
] - WOPRAI
Mon, December 11, 2023
[ Mon, Dec 11th 2023
] - WOPRAI
Fri, November 10, 2023
[ Fri, Nov 10th 2023
] - WOPRAI
Mon, October 30, 2023
[ Mon, Oct 30th 2023
] - WOPRAI
Wed, October 11, 2023
[ Wed, Oct 11th 2023
] - WOPRAI
Mon, July 24, 2023
[ Mon, Jul 24th 2023
] - WOPRAI
Tue, March 28, 2023
[ Tue, Mar 28th 2023
] - WOPRAI
Tue, March 14, 2023
[ Tue, Mar 14th 2023
] - WOPRAI
Tue, January 31, 2023
[ Tue, Jan 31st 2023
] - WOPRAI
Mon, December 19, 2022
[ Mon, Dec 19th 2022
] - WOPRAI
Mon, December 5, 2022
[ Mon, Dec 05th 2022
] - WOPRAI
Tue, November 8, 2022
[ Tue, Nov 08th 2022
] - WOPRAI
[ Tue, Nov 08th 2022
] - WOPRAI
Fri, September 9, 2022
[ Fri, Sep 09th 2022
] - WOPRAI
Tue, August 16, 2022
[ Tue, Aug 16th 2022
] - WOPRAI
Tue, May 24, 2022
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
Wed, April 20, 2022
[ Wed, Apr 20th 2022
] - WOPRAI
Tue, April 12, 2022
[ Tue, Apr 12th 2022
] - WOPRAI
Fri, April 1, 2022
[ Fri, Apr 01st 2022
] - WOPRAI
Thu, February 3, 2022
[ Thu, Feb 03rd 2022
] - WOPRAI
Tue, February 1, 2022
[ Tue, Feb 01st 2022
] - WOPRAI
Fri, December 17, 2021
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
Tue, November 23, 2021
[ Tue, Nov 23rd 2021
] - WOPRAI
Tue, September 7, 2021
[ Tue, Sep 07th 2021
] - WOPRAI
Chris Shibutani Maintained (AMLX) at Hold with Increased Target to $4 on, Jul 12th, 2024
Chris Shibutani of Goldman Sachs, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Hold with Increased Target from $3 to $4 on, Jul 12th, 2024.
Chris has made no other calls on AMLX in the last 4 months.
There are 3 other peers that have a rating on AMLX. Out of the 3 peers that are also analyzing AMLX, 2 agree with Chris's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Graig Suvannavejh of "Mizuho" Maintained at Hold with Decreased Target to $3 on, Tuesday, May 14th, 2024
- Joel Beatty of "Baird" Maintained at Hold with Decreased Target to $3 on, Thursday, April 11th, 2024
This is the rating of the analyst that currently disagrees with Chris
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $8 on, Wednesday, July 10th, 2024
